MPARK Stock Overview
Provides healthcare service in Turkey, Azerbaijan, and Hungary. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for MPARK from our risk checks.
MLP Saglik Hizmetleri A.S. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₺358.25 |
| 52 Week High | ₺392.50 |
| 52 Week Low | ₺128.30 |
| Beta | 0.23 |
| 11 Month Change | 8.73% |
| 3 Month Change | 8.89% |
| 1 Year Change | 126.03% |
| 33 Year Change | 1,055.65% |
| 5 Year Change | 2,258.46% |
| Change since IPO | 1,810.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| MPARK | TR Healthcare | TR Market | |
|---|---|---|---|
| 7D | -4.8% | 1.4% | -1.7% |
| 1Y | 126.0% | 67.0% | 6.4% |
Return vs Industry: MPARK exceeded the TR Healthcare industry which returned 67% over the past year.
Return vs Market: MPARK exceeded the TR Market which returned 6.4% over the past year.
Price Volatility
| MPARK volatility | |
|---|---|
| MPARK Average Weekly Movement | 6.7% |
| Healthcare Industry Average Movement | 6.6% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in TR Market | 8.9% |
| 10% least volatile stocks in TR Market | 4.6% |
Stable Share Price: MPARK has not had significant price volatility in the past 3 months compared to the TR market.
Volatility Over Time: MPARK's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 13,555 | Muharrem Usta | www.mlpcare.com |
MLP Saglik Hizmetleri A.S. provides healthcare service in Turkey, Azerbaijan, and Hungary. The company operates hospitals under the Liv Hospital and VM Medical Park names. It also provides treatment, laboratory, ancillary services, as well as trades in medical products.
MLP Saglik Hizmetleri A.S. Fundamentals Summary
| MPARK fundamental statistics | |
|---|---|
| Market cap | ₺68.29b |
| Earnings (TTM) | ₺5.63b |
| Revenue (TTM) | ₺28.14b |
12.2x
P/E Ratio2.4x
P/S RatioIs MPARK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MPARK income statement (TTM) | |
|---|---|
| Revenue | ₺28.14b |
| Cost of Revenue | ₺20.11b |
| Gross Profit | ₺8.03b |
| Other Expenses | ₺2.40b |
| Earnings | ₺5.63b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 29.47 |
| Gross Margin | 28.54% |
| Net Profit Margin | 20.01% |
| Debt/Equity Ratio | 18.0% |
How did MPARK perform over the long term?
See historical performance and comparison